March 1, 2021
Researchers from the University of Oxford have investigated the potential for the commonly used anti-malarial and pneumonia drug Atovaquone to improve lung tumour receptiveness to cancer treatments such as chemotherapy and radiotherapy. Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone […]
